ResMed - 30 Year Stock Price History | RMD
Historical daily share price chart and data for ResMed since 1995 adjusted for splits and dividends. The latest closing stock price for ResMed as of January 17, 2025 is 239.78.
- The all-time high ResMed stock closing price was 288.99 on September 08, 2021.
- The ResMed 52-week high stock price is 260.49, which is 8.6% above the current share price.
- The ResMed 52-week low stock price is 170.56, which is 28.9% below the current share price.
- The average ResMed stock price for the last 52 weeks is 216.34.
| ResMed Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 233.7282 | 228.4800 | 239.7800 | 228.4800 | 239.7800 | 4.85% |
| 2024 | 212.1304 | 170.1930 | 255.5251 | 164.2583 | 228.6900 | 34.18% |
| 2023 | 190.4778 | 205.1470 | 236.8641 | 132.9770 | 170.4308 | -16.53% |
| 2022 | 220.3680 | 252.6069 | 254.9484 | 187.0453 | 204.1855 | -19.47% |
| 2021 | 229.4694 | 205.0798 | 288.9862 | 173.7923 | 253.5511 | 23.41% |
| 2020 | 170.3590 | 149.5961 | 212.8170 | 109.8164 | 205.4471 | 38.34% |
| 2019 | 117.1445 | 106.4036 | 150.1615 | 87.1640 | 148.5037 | 36.99% |
| 2018 | 97.5649 | 80.2744 | 109.7927 | 80.2744 | 108.4028 | 36.38% |
| 2017 | 69.7736 | 57.0647 | 81.1285 | 56.9910 | 79.4860 | 39.07% |
| 2016 | 55.5275 | 47.0962 | 64.4185 | 46.3655 | 57.1568 | 18.02% |
| 2015 | 53.0935 | 50.5521 | 66.4494 | 44.3574 | 48.4312 | -2.30% |
| 2014 | 43.2907 | 39.9975 | 50.7467 | 36.3873 | 49.5706 | 21.62% |
| 2013 | 40.9687 | 36.1483 | 49.2018 | 36.1483 | 40.7594 | 15.22% |
| 2012 | 29.0102 | 21.6030 | 36.3951 | 20.9281 | 35.3740 | 65.10% |
| 2011 | 25.3883 | 29.5406 | 29.7600 | 19.7894 | 21.4258 | -26.67% |
| 2010 | 26.4679 | 22.2651 | 30.0383 | 21.3204 | 29.2201 | 32.54% |
| 2009 | 17.8518 | 16.1875 | 22.3832 | 13.4207 | 22.0458 | 39.46% |
| 2008 | 17.0572 | 21.6409 | 21.6409 | 12.5813 | 15.8079 | -28.65% |
| 2007 | 19.1417 | 21.1179 | 22.8851 | 16.7231 | 22.1555 | 6.73% |
| 2006 | 18.3387 | 16.1200 | 21.5439 | 15.5464 | 20.7594 | 28.48% |
| 2005 | 14.0709 | 10.7150 | 18.0179 | 10.5041 | 16.1579 | 49.94% |
| 2004 | 10.0200 | 8.8571 | 10.8732 | 8.5809 | 10.7762 | 23.01% |
| 2003 | 8.0789 | 6.5479 | 9.8040 | 6.2569 | 8.7601 | 35.89% |
| 2002 | 7.0625 | 11.2085 | 11.2085 | 5.2088 | 6.4467 | -43.31% |
| 2001 | 10.5545 | 8.3046 | 13.0221 | 7.7310 | 11.3709 | 35.21% |
| 2000 | 6.5163 | 4.3105 | 8.7517 | 4.2904 | 8.4101 | 91.04% |
| 1999 | 3.5199 | 4.5076 | 5.4239 | 2.0825 | 4.4022 | -8.00% |
| 1998 | 2.3718 | 1.4762 | 4.9821 | 1.4762 | 4.7850 | 222.77% |
| 1997 | 1.2442 | 1.1335 | 1.6344 | 0.8963 | 1.4825 | 27.81% |
| 1996 | 0.8511 | 0.6327 | 1.2126 | 0.5536 | 1.1599 | 69.23% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.199B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.826B | 25.11 |
| Stryker (SYK) | United States | $146.166B | 32.94 |
| Boston Scientific (BSX) | United States | $145.408B | 41.81 |
| EssilorLuxottica (ESLOY) | France | $115.383B | 0.00 |
| Medtronic (MDT) | Ireland | $112.944B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.849B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.827B | 27.18 |
| GE HealthCare Technologies (GEHC) | United States | $38.715B | 20.08 |
| Terumo (TRUMY) | Japan | $27.980B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.250B | 18.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.811B | 13.89 |
| Insulet (PODD) | United States | $19.347B | 77.04 |
| Baxter (BAX) | United States | $15.818B | 10.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.057B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.586B | 32.58 |
| BellRing Brands (BRBR) | United States | $9.323B | 37.51 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.360B | 14.78 |
| ICU Medical (ICUI) | United States | $4.012B | 38.20 |
| Prestige Consumer Healthcare (PBH) | United States | $3.882B | 19.31 |
| Haemonetics (HAE) | United States | $3.691B | 18.01 |
| Envista Holdings (NVST) | United States | $3.413B | 25.42 |
| Perrigo (PRGO) | Ireland | $3.252B | 9.57 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.807B | 18.07 |
| GN Store Nord (GNNDY) | Denmark | $2.585B | 16.58 |
| Neogen (NEOG) | United States | $2.508B | 28.90 |
| LeMaitre Vascular (LMAT) | United States | $2.227B | 54.13 |
| AtriCure (ATRC) | United States | $1.876B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.572B | 27.52 |
| AdaptHealth (AHCO) | United States | $1.416B | 10.11 |
| InMode (INMD) | Israel | $1.410B | 8.48 |
| BioLife Solutions (BLFS) | United States | $1.213B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.205B | 0.00 |
| Owens & Minor (OMI) | United States | $1.124B | 8.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.981B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.843B | 14.87 |
| CeriBell (CBLL) | United States | $0.754B | 0.00 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.623B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.557B | 24.58 |
| Omeros (OMER) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.23 |
| Valneva SE (VALN) | France | $0.355B | 0.00 |
| Quanterix (QTRX) | United States | $0.342B | 0.00 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.18 |
| Biote (BTMD) | United States | $0.306B | 6.71 |
| Sanara MedTech (SMTI) | United States | $0.285B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.25 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.245B | 51.20 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 3.18 |
| Aurora Cannabis (ACB) | Canada | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.56 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 102.30 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.77 |
| Veru (VERU) | United States | $0.143B | 0.00 |
| Jin Medical (ZJYL) | China | $0.143B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.87 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| INLIF (INLF) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.069B | 35.33 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |